TMRW Vault® Receives CE Marking for Medical Device Compliance in Europe

TMRW Vault® Receives CE Marking as a Medical Device



In a significant advancement for reproductive healthcare, Reprotech has announced that its innovative product, TMRW Vault®, has successfully achieved CE marking. This certification, which designates the device as a Class IIa medical device, aligns with the European Medical Device Regulation (MDR). This development enables TMRW Vault to be marketed across the European Union and other international markets that acknowledge the CE mark, opening doors to improved reproductive sample storage practices.

Importance of CE Marking in Healthcare



CE marking signifies that the product meets the stringent health, safety, and environmental protection standards set by the European Union. For Reprotech, obtaining this marking is not just a regulatory milestone; it is a testament to its commitment to enhancing patient care and elevating the standards of fertility practices.

The TMRW Vault system integrates advanced technology, providing features such as enhanced monitoring and scalable storage solutions. This is crucial for fertility clinics, particularly as they manage an increasing volume of frozen reproductive tissues. Historically, many clinics have relied on traditional, manual storage systems that often introduce operational inefficiencies and increase the risk of human error.

Features of TMRW Vault®



The TMRW Vault is a cutting-edge cryogenic storage unit designed to safely store liquid nitrogen for oocytes, embryos, and sperm. The system comes with a dedicated workstation that allows users to transfer samples into and out of the TMRW Vault easily and manage orders through its user-friendly software interface. Key features of the TMRW Vault include:

  • - Digital Sample Management: Leveraging CryoBeacon technology with RFID support and the ivfOS® software, the TMRW Vault provides digital verification of sample authenticity and location.
  • - Accessible Storage Technology: The Vault technology enables embryologists to conveniently store and retrieve samples while maintaining full digital traceability.
  • - Enhanced Monitoring: TMRW Overwatch® ensures continuous system checks, providing a safety net that reinforces operational reliability.
  • - Scalable Storage Capacity: The design can accommodate more samples in a compact footprint, maximizing available space in clinics.
  • - Seamless Integration: TMRW Vault integrates effortlessly with the broader TMRW ecosystem and off-site cryostorage services, enhancing operational flexibility.
  • - Quick Deployment: The system can be installed with minimal disruption to clinic operations, allowing for swift adaptation to enhanced storage methods.

The Collaborative Effort Behind TMRW Vault®



This achievement follows Reprotech’s recent merger with TMRW Life Sciences in April 2026, which combined decades of expertise in cryostorage with next-generation digital sample management technologies. Together with the acquisition of IMT Matcher in June 2025, the newly formed organization has created one of the industry's most comprehensive ecosystems. This includes sample monitoring, digital traceability, in-house and off-site cryostorage management, as well as administrative and billing management.

About Reprotech



Reprotech is recognized as a leading provider of products and services related to the preservation, management, and long-term storage of reproductive samples. The company’s unified portfolio encompasses seven purpose-built biorepositories, advanced cryostorage technologies, and cutting-edge global digital supply chain solutions. Through its collaboration with TMRW, Matcher, and Cryologix, Reprotech is dedicated to assisting fertility centers in reducing risks, enhancing sample traceability, and optimizing workflows to secure valuable samples throughout the entire process.

By setting stringent compliance standards and enhancing operational excellence, Reprotech is paving the way for an industry standard in protecting vital reproductive specimens. This marks a significant step forward in the journey towards efficient and safe reproductive healthcare solutions.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.